Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
Cancer Research Communications
|
August 22, 2024
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
Elisabeth Heath, Gregory Dyson, Jennifer R Ribeiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
Qiao-Li Wang, Chao Ma, Chen Yuan, et al.
The Lancet. Oncology
|
January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
Jingyuan Wang, Joanne Xiu, Alex Farrell, et al.
Clinical Colorectal Cancer
|
February 12, 2014
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147
Jocelin Huang, Suresh G Nair, Michelle R Mahoney, et al.
Journal of the National Cancer Institute
|
September 17, 2015
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Claire Gallois, Qian Shi, Levi D Pederson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Florian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2022
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer
Andreas Seeber, Francesca Battaglin, Kai Zimmer, et al.
NPJ Precision Oncology
|
July 3, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
Kai Zimmer, Florian Kocher, Gerold Untergasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04
Michael J O'Connell, Linda H Colangelo, Robert W Beart, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
Cancer Research Communications
|
August 22, 2024
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
Elisabeth Heath, Gregory Dyson, Jennifer R Ribeiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2023
Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
Qiao-Li Wang, Chao Ma, Chen Yuan, et al.
The Lancet. Oncology
|
January 21, 2023
Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study
Jingyuan Wang, Joanne Xiu, Alex Farrell, et al.
Clinical Colorectal Cancer
|
February 12, 2014
Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147
Jocelin Huang, Suresh G Nair, Michelle R Mahoney, et al.
Journal of the National Cancer Institute
|
September 17, 2015
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Claire Gallois, Qian Shi, Levi D Pederson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Florian Kocher, Alberto Puccini, Gerold Untergasser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2022
Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer
Andreas Seeber, Francesca Battaglin, Kai Zimmer, et al.
NPJ Precision Oncology
|
July 3, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
Kai Zimmer, Florian Kocher, Gerold Untergasser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04
Michael J O'Connell, Linda H Colangelo, Robert W Beart, et al.
Page
of 19